Jubilant Pharmova Schedules Board Meeting to Review Q1 FY27 Financial Results

Jubilant Pharmova Schedules Board Meeting to Review Q1 FY27 Financial Results​

Jubilant Pharmova Limited has scheduled a meeting of its Board of Directors. The gathering is set for Friday, August 07, 2026.

The primary focus of the board meeting will be to consider the Un-audited Standalone and Consolidated Financial Results of the Company. These results pertain to the quarter that ended June 30, 2026.

The scheduled meeting aims to review the financial performance for the period. The document pertaining to these results is planned to be simultaneously posted on the company's official website.

JUBLPHARMA Stock Price Movement​

Shares of Jubilant Pharmova Limited shed 2.16% in post-market trading today, closing at ₹961.65. Total traded volumes for the stock reached 70,552 shares during the session.

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.